Granted Patent B2

US 12,349,899 · App. 17/950,226 · Granted Jul 8, 2025

Inventors: Michael J. Vendely (Lebanon, OH); Trevor J. Barton (Cincinnati, OH); Jason L. Harris (Lebanon, OH); Charles J. Scheib (Loveland, OH); Emily A. Schellin (Cincinnati, OH); Prudence A. Vulhop (Warsaw, IN); Steven G. Hall (Cincinnati, OH); Victoria Dalessandro (Scotch Plains, NJ); Jackie Donners (Pennington, NJ); Mark D. Timmer (Jersey City, NJ); Rao S. Bezwada (Whitehouse Station, NJ); Aidan Craigwood (Cambridge, GB); Caroline Hagerman (Cambridge, GB); Ashley Easter (Cambridge, GB); Kathrin Holtzmann (Cambridge, GB); Frederick E. Shelton, IV (Hillsboro, OH); Mark S. Zeiner (Mason, OH)

Assignee: Cilag GmbH International

A61B17/068A61B17/07207A61B17/07292A61B42/00A61B50/30A61B50/31A61B90/90A61B2017/00115A61B2017/00221A61B2017/00526A61B2017/00734A61B2017/00893A61B2017/00946A61B2017/00951A61B2017/0688A61B2017/07271A61B2050/005A61B2050/0059A61B2050/0065A61B2050/314A61B2090/037A61B2090/0807A61B2090/081

Abstract

Claims (44)

1. A buttress assembly configured for use with an end effector of a surgical stapler, comprising:

(a) a buttress body; and

(b) an adhesive layer disposed over the buttress body, wherein the adhesive layer includes a pressure sensitive adhesive having an embedded medicant, wherein the adhesive layer is configured to releasably adhere to one of an anvil or a stapling assembly of the end effector in response to closure of the end effector on the buttress assembly,

wherein the buttress body is configured to contact tissue clamped by the end effector during closure thereof,

wherein the buttress body is further configured to be pierced and captured by staples ejected from the stapling assembly into the clamped tissue and thereby reinforce the engagement between the ejected staples with the clamped tissue,

wherein the embedded medicant is configured to affect a physiological response in the clamped tissue.

2. The buttress assembly of claim 1 , wherein the adhesive layer is configured to release the embedded medicant to the tissue.

3. The buttress assembly of claim 2 , wherein the adhesive layer is configured to release the embedded medicant to the tissue substantially immediately in response to the buttress body being pierced and captured by the staples ejected from the stapling assembly into the clamped tissue.

4. The buttress assembly of claim 1 , wherein the embedded medicant includes a hemostatic agent.

5. The buttress assembly of claim 1 , wherein the embedded medicant includes an adhesion prevention agent.

6. The buttress assembly of claim 1 , wherein the embedded medicant includes a healing cascade impacting agent.

7. The buttress assembly of claim 1 , wherein the embedded medicant includes an antimicrobial agent.

8. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive is absorbable.

9. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive includes a polymer.

10. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive includes an organic adhesive blend.

11. The buttress assembly of claim 10 , wherein the organic adhesive blend includes one or more plastic fats.

12. The buttress assembly of claim 10 , wherein the organic adhesive blend includes one or more sorbents.

13. The buttress assembly of claim 1 , wherein at least the buttress body of the buttress assembly is configured to separate from the one of the anvil or the stapling assembly in response to opening of the end effector after the staples have been ejected into the clamped tissue.

14. A buttress applier cartridge configured for use with an end effector of a surgical stapler, comprising:

(a) a platform;

(b) the buttress assembly of claim 1 disposed on the platform; and

(c) a retainer configured to releasably retain the buttress assembly on the platform.

15. An assembly, comprising:

(a) an end effector, comprising:

(i) an anvil, and

(ii) a stapling assembly; and

(b) the buttress assembly of claim 1 , wherein the adhesive layer of the buttress assembly is releasably adhered to one of the anvil or the stapling assembly of the end effector.

16. The buttress assembly of claim 1 , wherein the pressure sensitive adhesive is flowable.

17. The buttress assembly of claim 1 , wherein the adhesive layer covers an upper surface of the buttress body.

18. The buttress assembly of claim 1 , wherein the adhesive layer is exposed.

19. A buttress assembly configured for use with an end effector of a surgical stapler, comprising:

(a) a buttress body; and

(b) an adhesive layer disposed over the buttress body, wherein the adhesive layer includes a pressure sensitive adhesive having an embedded medicant, wherein the adhesive layer is configured to releasably adhere to one of an anvil or a stapling assembly of the end effector in response to closure of the end effector on the buttress assembly,

wherein the buttress body is configured to contact tissue clamped by the end effector during closure thereof,

wherein the buttress body is further configured to be pierced and captured by staples ejected from the stapling assembly into the clamped tissue and thereby reinforce the engagement between the ejected staples with the clamped tissue,

wherein the embedded medicant is configured to affect a physiological response in the clamped tissue,

wherein the embedded medicant includes both a hemostatic agent and an adhesion prevention agent.

20. A buttress assembly configured for use with an end effector of a surgical stapler, comprising:

(a) a buttress body; and

(b) an adhesive layer disposed over the buttress body, wherein the adhesive layer includes a pressure sensitive adhesive having an embedded medicant, wherein the adhesive layer is configured to releasably adhere to one of an anvil or a stapling assembly of the end effector in response to closure of the end effector on the buttress assembly,

wherein the buttress body is configured to contact tissue clamped by the end effector during closure thereof,

wherein the buttress body is further configured to be pierced and captured by staples ejected from the stapling assembly into the clamped tissue and thereby reinforce the engagement between the ejected staples with the clamped tissue,

wherein the embedded medicant is configured to affect a physiological response in the clamped tissue,

wherein the pressure sensitive adhesive is both flowable and absorbable.

Continuity (5)

References Cited (215)